InspireMD Announces Third Quarter 2019 Financial Results
12 nov. 2019 07h00 HE
|
InspireMD, Inc.
Strong revenue driven by record orders of CGuard™ EPS Management to host investor conference call today, November 12, at 8:30am ET TEL AVIV, Israel, Nov. 12, 2019 (GLOBE NEWSWIRE) -- InspireMD,...
InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12
05 nov. 2019 08h00 HE
|
InspireMD, Inc.
TEL AVIV, Israel, Nov. 05, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...
InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering
19 sept. 2019 21h12 HE
|
InspireMD, Inc.
TEL AVIV, Israel, Sept. 19, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by...
InspireMD Provides Business Update
09 sept. 2019 08h05 HE
|
InspireMD, Inc.
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by...
InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference
09 sept. 2019 08h00 HE
|
InspireMD, Inc.
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid...
InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency
09 août 2019 16h30 HE
|
InspireMD, Inc.
TEL AVIV, Israel, Aug. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...
InspireMD Announces Second Quarter 2019 Financial Results
06 août 2019 07h00 HE
|
InspireMD, Inc.
U.S. Investigational Device Exemption (IDE) application submitted to FDA Company to host investor conference call today, August 6, at 8:00am ET TEL AVIV, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) --...
InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6
30 juil. 2019 16h05 HE
|
InspireMD, Inc.
TEL AVIV, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...
InspireMD Announces First Quarter 2019 Financial Results
14 mai 2019 07h00 HE
|
InspireMD, Inc.
On-Track to Submit U.S. IDE expected in Mid-2019 Company to Host Investor Conference Call at 8:00am ET TEL AVIV, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR),...
InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14
07 mai 2019 08h00 HE
|
InspireMD, Inc.
TEL AVIV, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...